Skip to content
October 10, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Metastatic Breast Cancer Research
  • A Global Beacon of Hope: #LightUpMBC Shines a Necessary Spotlight on Metastatic Breast Cancer
  • Metastatic Breast Cancer Research

A Global Beacon of Hope: #LightUpMBC Shines a Necessary Spotlight on Metastatic Breast Cancer

Basiran October 10, 2026 7 minutes read
a-global-beacon-of-hope-lightupmbc-shines-a-necessary-spotlight-on-metastatic-breast-cancer

NEW YORK, NY – As the calendar turns to October, the world is often awash in a sea of pink, marking Breast Cancer Awareness Month. While the campaign has been instrumental in promoting early detection and celebrating survivorship for early-stage patients, a critical, often life-altering reality is frequently left in the shadows: Metastatic Breast Cancer (MBC).

On October 13, National Metastatic Breast Cancer Awareness Day, the nonprofit organization METAvivor Research and Support is spearheading a monumental global movement. The #LightUpMBC campaign will see more than 325 iconic landmarks across 20 countries, 195 cities, and all 50 U.S. states bathed in the tri-colors of teal, green, and pink—the official colors of MBC awareness. More than just a visual spectacle, this campaign serves as a poignant reminder that while advancements in medicine continue, Stage 4 breast cancer remains a terminal diagnosis for which there is currently no cure.

The Reality of Stage 4: What is Metastatic Breast Cancer?

To understand the urgency behind #LightUpMBC, one must first grasp the clinical reality of the disease. Metastatic breast cancer, or Stage 4, occurs when cancer cells migrate from the breast to distant sites in the body, most commonly the bones, liver, lungs, or brain.

It is a common misconception that Stage 4 is a different disease; it remains breast cancer regardless of where it has spread. For some patients, this is their initial diagnosis. For others, it is the result of a recurrence, emerging months, years, or even decades after they have successfully completed treatment for earlier-stage breast cancer.

"For those of us living with MBC, treatment is not a temporary phase—it is a lifelong necessity," explains Dr. Kelly Shanahan, Board President of METAvivor. "Even when a scan comes back ‘clean’ or shows no evidence of disease, that does not mean we are cured. We are in a state of constant management, hoping to keep the cancer stable and preserve our quality of life while dodging the inevitable resistance that develops against existing therapies."

The statistics are sobering. In the United States alone, an estimated 42,670 people are expected to lose their lives to breast cancer in 2026. This translates to approximately 117 deaths every single day. These numbers underscore why research—specifically research focused on the metastatic stage—is not merely an academic endeavor; it is a fight for survival.

A Chronology of Advocacy: From a Single Light to a Global Movement

The #LightUpMBC initiative began with a personal mission of love and a vision for change. In 2017, the movement started with a single landmark—the Memorial Bridge in Portsmouth, New Hampshire. It was the brainchild of Laura Inahara, who sought to honor her best friend, Jessica Moore, who had tragically passed away from metastatic breast cancer at the age of 36.

Jessica’s original dream was modest: she wanted to see one local landmark illuminated to raise awareness for a disease that felt invisible to the public eye. Following her passing, Inahara transformed that grief into a global call to action.

  • 2017: The inaugural lighting of the Memorial Bridge in Portsmouth, NH, marks the beginning of the campaign.
  • 2018–2020: The movement gains momentum, with increasing numbers of city officials and landmark management boards agreeing to light up in support of the MBC community.
  • 2021–2025: The campaign evolves into a multi-national effort, integrating virtual components and live-streamed educational programming to reach a wider audience during the pandemic and beyond.
  • 2026: #LightUpMBC achieves its largest scale yet, with over 325 landmarks participating worldwide, including architectural giants like One World Trade Center, the Willis Tower, and Niagara Falls.

What began as a localized tribute has blossomed into a global powerhouse, raising over $2.7 million for critical MBC research. The expansion of this movement represents a significant shift in public perception, moving from passive awareness to active, funded advocacy.

The Pillars of the Campaign: Research, Advocacy, and Community

METAvivor stands as the only national organization in the United States that exclusively funds Stage 4 metastatic breast cancer research. Unlike many broad-spectrum cancer organizations that prioritize early-stage screening, METAvivor focuses its resources on the "terminal" end of the spectrum, where the need is most desperate.

The organization utilizes a rigorous, two-tier grant selection process:

  1. Scientific Peer Review: Experts evaluate the feasibility and potential impact of the proposed research.
  2. Patient Advocate Review: Individuals living with MBC review the proposals to ensure the research addresses the real-world needs and quality-of-life concerns of patients.

This unique process ensures that every dollar raised by #LightUpMBC is directed toward projects that aim to transform MBC from a terminal, fatal disease into a chronic, survivable condition. As Dr. Shanahan notes, the research funded by METAvivor is the primary hope for those currently navigating the complexities of Stage 4 disease.

Official Responses and Voices of Experience

The #LightUpMBC Live broadcast, scheduled for October 13 at 8 p.m. ET, serves as the centerpiece of the annual campaign. Hosted by Tami Eagle Bowling, who has lived with MBC for 11 years, and Broadway performer Kara Lindsay, the event promises to be a powerful intersection of science, storytelling, and the arts.

"When I was diagnosed in 2013, I didn’t think I’d be here 13 years later," Dr. Shanahan reflects. Her story is a testament to the power of medical progress, yet she remains acutely aware of the fragility of her situation. "We need people to understand that ‘awareness’ isn’t enough. We need action. We need funding. And we need a community that understands that living with Stage 4 is not the same as ‘surviving’ early-stage breast cancer."

The broadcast will feature a star-studded lineup of talent, including Tony Award winner Victoria Clark and renowned voice artist Tony Daniels, who have lent their voices to the cause. However, the most important voices remain those of the patients themselves. The program will share live, on-the-ground stories from various illuminated landmarks, bridging the gap between the symbolic lights and the human beings they represent.

Implications for the Future of MBC Care

The implications of the #LightUpMBC campaign are far-reaching. By shifting the conversation toward the realities of metastatic disease, the campaign challenges the medical community and the public to rethink how breast cancer is funded and treated.

Addressing the Research Gap

Historically, metastatic research has been underfunded relative to the number of deaths it causes. #LightUpMBC is directly correcting this imbalance. By providing a platform for patient-driven funding, METAvivor empowers individuals to take charge of their own medical destinies.

Reducing Stigma and Isolation

For many patients, a diagnosis of Stage 4 is isolating. The sight of major international landmarks glowing in their honor provides a sense of community and visibility that is often missing from traditional pink-ribbon campaigns. It validates their struggle and acknowledges their presence in the world.

A Call for Global Engagement

The participation of landmarks from the Ness Bridge in Scotland to the Mactan-Cebu Airport in the Philippines illustrates that metastatic breast cancer is a global crisis. The campaign’s success in these diverse regions suggests that the desire for a cure is a universal language, transcending borders and political lines.

How to Get Involved

As the sun sets on October 13, the public is encouraged to participate in the #LightUpMBC movement. Whether by visiting a local landmark, watching the live stream, or contributing to the research fund, every action counts.

  • Watch the Broadcast: The #LightUpMBC Live event will be available for free on the METAvivor YouTube channel and METAvivor Facebook Live.
  • Share the Light: Attendees are encouraged to photograph participating landmarks and share them on social media using the hashtags #LightUpMBC and #METAvivor, tagging @LightUpMBC.
  • Support the Mission: 100% of the net proceeds from the campaign are funneled directly into research grants. Donations and information on participating landmarks can be found at www.lightupmbc.org.

In a world that often prefers to look away from the harsh realities of terminal illness, #LightUpMBC asks us to look up—to see the light, to honor the struggle, and to join the fight to turn a terminal diagnosis into a future of hope and survival. As the lights flicker to life across the globe, they serve as a silent, glowing vow: the battle against metastatic breast cancer will not be fought in the dark.

About the Author

Basiran

Author

View All Posts

Post navigation

Previous: A Beacon of Resilience: WHO Director-General Strengthens Global Health Ties During Landmark Visit to Jordan
Next: The Digital Renaissance of Pathology: Mining Archives to Redefine Preclinical Research

Related Stories

a-beacon-of-hope-global-landmark-campaign-shines-light-on-the-invisible-crisis-of-metastatic-breast-cancer
  • Metastatic Breast Cancer Research

A Beacon of Hope: Global Landmark Campaign Shines Light on the "Invisible" Crisis of Metastatic Breast Cancer

Nila Kartika Wati October 10, 2026
turning-darkness-into-hope-the-global-movement-to-illuminate-metastatic-breast-cancer-awareness
  • Metastatic Breast Cancer Research

Turning Darkness Into Hope: The Global Movement to Illuminate Metastatic Breast Cancer Awareness

Jia Lissa October 10, 2026
a-global-beacon-of-hope-the-lightupmbc-campaign-targets-metastatic-breast-cancer
  • Metastatic Breast Cancer Research

A Global Beacon of Hope: The #LightUpMBC Campaign Targets Metastatic Breast Cancer

Muslim October 9, 2026

Recent Posts

  • Unmasking Cancer’s Master Manipulator: OU Research Reveals How Aggressive Breast Tumors Hijack the Immune System to Fuel Growth
  • Alumis Poised to Enter Crowded Psoriasis Market with Promising TYK2 Inhibitor, Envudeucitinib
  • Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Deep Dive into Emerging Research
  • Global Landmarks to Glow Teal, Green, and Pink: The 2026 Push to Fund Metastatic Breast Cancer Research
  • FDA Expands First-Line Maintenance Options for HER2-Positive Metastatic Breast Cancer: A New Era of Targeted Triple Therapy

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

unmasking-cancers-master-manipulator-ou-research-reveals-how-aggressive-breast-tumors-hijack-the-immune-system-to-fuel-growth
  • Medical Research and Clinical Trials

Unmasking Cancer’s Master Manipulator: OU Research Reveals How Aggressive Breast Tumors Hijack the Immune System to Fuel Growth

Evan Lee Salim October 10, 2026
alumis-poised-to-enter-crowded-psoriasis-market-with-promising-tyk2-inhibitor-envudeucitinib
  • Medical Research and Clinical Trials

Alumis Poised to Enter Crowded Psoriasis Market with Promising TYK2 Inhibitor, Envudeucitinib

Nana Wu October 10, 2026
navigating-the-intersection-of-glp-1-medications-and-breast-cancer-a-deep-dive-into-emerging-research
  • Patient Advocacy and Support

Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Deep Dive into Emerging Research

Jia Lissa October 10, 2026
global-landmarks-to-glow-teal-green-and-pink-the-2026-push-to-fund-metastatic-breast-cancer-research
  • Patient Advocacy and Support

Global Landmarks to Glow Teal, Green, and Pink: The 2026 Push to Fund Metastatic Breast Cancer Research

Nana October 10, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.